Tvardi Therapeutics, Inc. Common Stock TVRD

$1.86 -2.11% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-14 View →
8-K FORM 8-K 2026-08-14 View →
8-K FORM 8-K 2026-07-30 View →
8-K FORM 8-K 2026-07-17 View →
424B5 424B5 2026-07-17 View →
8-K FORM 8-K 2026-07-07 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
8-K FORM 8-K 2026-06-11 View →
10-Q 10-Q 2026-05-08 View →
8-K FORM 8-K 2026-05-08 View →
S-3 S-3 2026-05-01 View →
DEF 14A DEF 14A 2026-04-23 View →
10-K 10-K 2026-03-31 View →
8-K FORM 8-K 2026-03-31 View →
8-K FORM 8-K 2026-03-06 View →
4 Insider transaction 2026-02-02 View →
4 Insider transaction 2026-02-02 View →
4 Insider transaction 2026-02-02 View →
4 Insider transaction 2026-02-02 View →
8-K FORM 8-K 2026-01-16 View →
8-K FORM 8-K 2025-12-18 View →
4 Insider transaction 2025-12-18 View →
4 Insider transaction 2025-12-18 View →
4 Insider transaction 2025-12-18 View →
4 Insider transaction 2025-12-18 View →
8-K FORM 8-K 2025-11-19 View →
8-K FORM 8-K 2025-11-13 View →
10-Q 10-Q 2025-11-13 View →
8-K FORM 8-K 2025-10-14 View →
8-K FORM 8-K 2025-08-14 View →
10-Q 10-Q 2025-08-14 View →
4 Insider transaction 2025-08-05 View →
8-K FORM 8-K 2025-07-14 View →
8-K FORM 8-K 2025-06-09 View →
S-1 FORM S-1 2025-05-30 View →
8-K FORM 8-K 2025-05-27 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.86
Market Cap
$25.34 million
52-Week Range
$1.50 – $43.65
Average Volume
4.59 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.